Browse our law brief articles and blogs, aimed at addressing the practical implications of the latest legal developments affecting you and your organisation.
We discuss two non-binding employment tribunal decisions concerning measures to protect pregnant workers during the pandemic and the dismissal of an employee who refuses to obey a management instruction due to COVID-related risks be automatically unfair.
A recent study by Acas shows that over half of UK employers expect an increased demand for flexible working from employees in light of the coronavirus pandemic.
Following a recent flurry of cases arising out of coronavirus (COVID-19) and the resulting impact on employment, we review three notable cases and what they could mean for the higher education sector.
In the case of Triple Point Technology Inc v PTT Public Co Ltd, the Supreme Court has ruled on a controversial Court of Appeal decision as to whether liquidated damages provisions in a contact apply for work that is never delivered.
Continuing with our 'Q&A' series of articles, our Legacy Protection team's focus this time turns to higher education institutions as beneficiaries of an estate and in particular the early days of estate administration.
The continued rollout of coronavirus (COVID-19) vaccinations raise many questions for employers. These FAQs answer the most common questions employers have around vaccinations and their employees.
One of the many new issues the COVID-19 pandemic has presented for the HR community in higher education is the question of whether they can require employees to be based in the UK.
A part-time employee recently argued he was treated less favourably, as he was denied access to breaks due to working shorter shifts than his full-time colleagues.
The Employment Appeal Tribunal recently held that a claim brought by employees for unlawful inducement was brought out of time, and was therefore dismissed.
On 5 September the Secretary of State for BEIS intervened on national security grounds in the proposed acquisition by a company apparently associated with a Chinese academic of a group of small UK companies engaged in commercialising graphene.
A recent case demonstrates the importance of having clear contractual wording in relation to insurance backed benefits and undertaking proper due diligence on a TUPE transfer.
NHS England will soon be offering a 'game-changing' anti-cholesterol drug for hundreds of thousands of people for whom statins and other treatments have not worked.
The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation asking the medical community, patients and the public for their views on its proposed plans for a new regulatory framework for Point of Care (POC) manufacturing.